Abdominal tuberculosis co-occurring with HIV infection or AIDS is a clinically important scenario that calls for prompt, deliberate management. The immune status of the patient shapes both the urgency of treatment initiation and the considerations that guide the overall approach.
This protocol addresses patients with abdominal tuberculosis who have concurrent HIV infection or AIDS. Treatment principles in this population follow the same framework as in patients without HIV, but clinicians should be aware that multidrug-resistant tuberculosis is more prevalent among patients with AIDS.
Management centres on a standard antituberculous drug regimen that is initiated immediately, regardless of CD4 count. The full combination of agents, course duration, and sequencing details are available in the structured protocol below.